Leading diagnostic companies by revenue 2024| ��ƽ��

Leading medical diagnostics companies based on revenue in 2024 (in billion U.S. dollars)

Characteristic	Revenue in billion U.S. dollars
Siemens Healthineers	17.61
GE Healthcare	16.49
Roche	15.85
Danaher	9.78
Quest Diagnostics	9.61
Abbott Laboratories	9.34
Philips	9.15
Becton-Dickinson & Co.	5.2
Thermo Fisher Scientific	4.51
IDEXX Laboratories	3.71

Download

Source

Show detailed source information?

Already a member?

Sources

Release date

2025

More information

Region

Worldwide

Survey time period

2024

Supplementary notes

Based on the companies' revenue in the diagnostics segment.

Citation formats

In 2023, German company Siemens Healthineers had the highest revenue worldwide from medical diagnostics, at over 17.6 billion U.S. dollars. This was followed by GE Healthcare, which had revenue from diagnostics of around 16.5 billion U.S. dollars. In vitro diagnostics (IVD) are one of the prominent segments of the diagnostics industry overall. Although also included in the industry are devices that scan or image parts of the body, such as MRIs, CT scans, and ultrasounds.

Market share in the IVD markets

In 2022, Abbott Laboratories occupied 20 percent of the IVD market in the United States, followed by Danaher with 11 percent market share. Similarly, Roche Diagnostics and Abbott Laboratories had the largest market share in Europe in the given year.

IVD industry revenue and market size

The outbreak of the COVID-19 pandemic caused a huge demand for tests that could detect the disease. The IVD industry therefore underwent massive growth in 2020 and 2021. In 2024, the global revenue of the in vitro diagnostics industry amounted to nearly 89 billion U.S. dollars, with an expected growth to 103 billion U.S. dollars by 2029.